For the EGFR wild‐type samples, the top six pathways selected for analysis include ECM‐receptor interaction, cancer miRNA in cancer, focal adhesion, PI3 K‐Akt signaling pathway, MAPK signaling pathway, and Ras signaling pathway (Figure 6B). This evidence concerns the gene AKT1 and cancer.